| First Author | Kasashima H | Year | 2021 |
| Journal | Dev Cell | Volume | 56 |
| Issue | 1 | Pages | 95-110.e10 |
| PubMed ID | 33207226 | Mgi Jnum | J:300513 |
| Mgi Id | MGI:6503798 | Doi | 10.1016/j.devcel.2020.10.014 |
| Citation | Kasashima H, et al. (2021) Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population. Dev Cell 56(1):95-110.e10 |
| abstractText | Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well understood. We show that the upregulation of SOX2 is central to this process, which is repressed by protein kinase Czeta (PKCzeta). PKCzeta deficiency activates the reprogramming of colonic fibroblasts to generate a predominant SOX2-dependent CAF population expressing the WNT regulator Sfrp2 as its top biomarker. SOX2 directly binds the Sfrp1/2 promoters, and the inactivation of Sox2 or Sfrp1/2 in CAFs impaired the induction of migration and invasion of colon cancer cells, as well as their tumorigenicity in vivo. Importantly, recurrence-free and overall survival of colorectal cancer (CRC) patients negatively correlates with stromal PKCzeta levels. Also, SOX2 expression in the stroma is associated with CRC T invasion and worse prognosis of recurrence-free survival. Therefore, the PKCzeta-SOX2 axis emerges as a critical step in the control of CAF pro-tumorigenic potential. |
